Robert L. Martuza
#144,193
Most Influential Person Now
Robert L. Martuza's AcademicInfluence.com Rankings
Robert L. Martuzabiology Degrees
Biology
#10371
World Rank
#13697
Historical Rank
Computational Biology
#210
World Rank
#211
Historical Rank

Download Badge
Biology
Robert L. Martuza's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Robert L. Martuza Influential?
(Suggest an Edit or Addition)Robert L. Martuza's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma (2014) (3192)
- A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor (1993) (1146)
- Meningioma: analysis of recurrence and progression following neurosurgical resection. (1985) (990)
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial (2000) (949)
- Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas (1995) (776)
- Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma (2016) (731)
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells (2014) (712)
- Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma (1988) (636)
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directions (2001) (515)
- Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma (1986) (511)
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy (2009) (443)
- Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 (1987) (443)
- Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing (2001) (382)
- LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION (2009) (374)
- Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene (1987) (370)
- Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade. (2017) (364)
- Sequestration of T-cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2018) (341)
- Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. (2009) (316)
- Molecular genetic approach to human meningioma: loss of genes on chromosome 22. (1987) (306)
- Oncolytic viral therapies – the clinical experience (2005) (293)
- Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. (1999) (258)
- Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. (1994) (253)
- Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. (1987) (243)
- An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. (2013) (240)
- Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. (1992) (233)
- Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. (1991) (222)
- Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. (1995) (211)
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. (2012) (204)
- Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. (1999) (200)
- Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. (1991) (195)
- Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates (1999) (180)
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model (2013) (169)
- Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. (1989) (164)
- In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. (1998) (163)
- Preservation of hearing and facial nerve function in resection of acoustic neuroma (1992) (160)
- Treatment of glioma by engineered interleukin 4-secreting cells. (1993) (159)
- Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. (1999) (157)
- Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. (1995) (155)
- Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. (2007) (155)
- Psychosurgery: past, present, and future (2005) (154)
- Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. (1991) (153)
- Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. (1990) (152)
- Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication. (2006) (145)
- TP53 Gene Mutations and 17p Deletions in Human Astrocytomas (1991) (140)
- Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. (1998) (140)
- Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice (2000) (135)
- The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells (2001) (133)
- Conditionally replicating herpes vectors for cancer therapy. (2000) (129)
- Preservation of hearing in surgical removal of acoustic neuromas of the internal auditory canal and cerebellar pontine angle (1987) (124)
- Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. (1982) (122)
- Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. (1999) (120)
- Modulation of meningioma cell growth by sex steroid hormones in vitro. (1985) (117)
- Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus (1997) (114)
- Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. (2000) (112)
- Stereotactic Radiotherapy for Vestibular Schwannomas: Favorable Outcome with Minimal Toxicity (2005) (111)
- Proton Beam Radiosurgery for Vestibular Schwannoma: Tumor Control and Cranial Nerve Toxicity (2003) (109)
- Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers (2006) (107)
- Transcriptional targeting of herpes simplex virus for cell-specific replication (1997) (101)
- Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. (2012) (100)
- In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. (2001) (95)
- Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice (1999) (95)
- Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system. (2005) (94)
- Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. (2015) (92)
- Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus. (2000) (91)
- Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. (1981) (90)
- Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. (1993) (89)
- Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. (1990) (89)
- Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. (1985) (89)
- Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: A light and electron microscopic study (1992) (88)
- Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors (2012) (87)
- Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. (1997) (80)
- Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. (2008) (78)
- The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model (1986) (77)
- Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. (2016) (76)
- Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. (2006) (76)
- Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts (2011) (73)
- Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. (2013) (72)
- Dominant-Negative Fibroblast Growth Factor Receptor Expression Enhances Antitumoral Potency of Oncolytic Herpes Simplex Virus in Neural Tumors (2006) (70)
- Laser-induced fluorescence: experimental intraoperative delineation of tumor resection margins. (1992) (70)
- Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates. (2001) (69)
- Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo (1999) (68)
- Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma (2019) (68)
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells (2011) (68)
- Hypoxia enhances the replication of oncolytic herpes simplex virus. (2009) (67)
- Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma. (2012) (66)
- Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain (2005) (66)
- AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. (1994) (65)
- Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. (1986) (64)
- Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide. (2007) (63)
- Symptomatic spinal epidural lipomatosis associated with Cushing's syndrome. (1981) (59)
- Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer. (2001) (57)
- Neurofibromatosis type 2 appears to be a genetically homogeneous disease. (1992) (57)
- Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy. (1999) (55)
- Oncolytic Herpes Simplex Virus Vector G47Δ in Combination with Androgen Ablation for the Treatment of Human Prostate Adenocarcinoma (2005) (54)
- Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma. (2018) (53)
- Identification of diagnostic serum protein profiles of glioblastoma patients (2010) (51)
- Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. (2013) (50)
- Glial growth factor—like activity in Schwann cell tumors (1986) (50)
- Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses. (2007) (50)
- The nature and origin of the melanin macroglobule. (1984) (49)
- New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. (2005) (49)
- Cerebellopontine Angle Meningiomas: Clinical Manifestations and Diagnosis (1985) (49)
- Stereotactic radiofrequency thermal cingulotomy for obsessive compulsive disorder. (1961) (46)
- Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. (2004) (46)
- Clonal origin of pituitary adenomas. (1990) (45)
- Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models (2012) (45)
- Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma (2017) (43)
- Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. (2006) (43)
- Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors (2000) (43)
- Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. (1990) (43)
- Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1 (2004) (42)
- Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. (1985) (42)
- Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases (2006) (42)
- Clinical Mutations in the L1 Neural Cell Adhesion Molecule Affect Cell-Surface Expression (2000) (42)
- Long-term hearing results in patients after surgical removal of acoustic tumors with hearing preservation. (1992) (42)
- Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2. (2005) (40)
- Act locally, think globally (1997) (40)
- Systemic Oncolytic Herpes Virus Therapy of Poorly Immunogenic Prostate Cancer Metastatic to Lung (2006) (38)
- Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma. (2012) (37)
- Molecular Genetics of Neurofibromatosis 2 and Related Tumors (Acoustic Neuroma and Meningioma) a (1991) (36)
- Treatment of Implantable NF2 Schwannoma Tumor Models with Oncolytic Herpes Simplex Virus G47Δ (2007) (36)
- Oncolytic Herpes Simplex Virus Counteracts the Hypoxia‐Induced Modulation of Glioblastoma Stem‐Like Cells (2012) (36)
- Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models (2018) (36)
- Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells (2009) (35)
- Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. (2017) (35)
- Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer (2010) (35)
- Enhanced in vitro uptake and retention of 3H-tetraphenylphosphonium by nervous system tumor cells. (1991) (34)
- Craniofacial Hemangiopericytoma Associated with Oncogenic Osteomalacia: Case Report (2004) (33)
- The molecular biology of human glial tumors (1988) (32)
- Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes. (2008) (32)
- Herpes Simplex Virus Us3(−) Mutant as Oncolytic Strategy and Synergizes with Phosphatidylinositol 3-Kinase-Akt–Targeting Molecular Therapeutics (2007) (32)
- Loss of the Y chromosome in meningiomas. A molecular genetic approach. (1990) (32)
- Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (32)
- Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation. (2001) (31)
- Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models (2017) (30)
- Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication. (2010) (30)
- Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection. (1986) (30)
- Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth. (1989) (29)
- Growth of human schwannomas in the subrenal capsule of the nude mouse. (1990) (28)
- Advances in Neurofibromatosis 2 (NF2): A Workshop Report (2000) (28)
- Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. (2014) (28)
- The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma (2008) (28)
- Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma (2020) (28)
- Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. (1999) (27)
- Capgras syndrome with subarachnoid hemorrhage. (1986) (27)
- A vascular sarcoid mass mimicking a convexity meningioma (2000) (27)
- Genetic Determinants of Hearing Loss Associated With Vestibular Schwannomas (2009) (26)
- Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells (2008) (26)
- Bilateral Acoustic Neuromas (1982) (26)
- Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma (2014) (26)
- Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma (2020) (25)
- Erratum: Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses (Cancer Research (2007) 67, (9398-9406)) (2007) (25)
- Targeting Hypoxia-Inducible Factor 1&agr; in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment (2015) (24)
- Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470 (2005) (24)
- Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse (1992) (22)
- Diagnosis of cerebellopontine angle tumors. (1985) (22)
- Expression of thymidine kinase is essential to low dose radiation resistance of rat glioma cells. (1994) (22)
- A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. (2016) (22)
- Clonal analysis of human meningiomas and schwannomas. (1990) (22)
- Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells (2018) (21)
- Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model (2001) (21)
- Postoperative imaging of vestibular schwannomas. (2012) (21)
- Loss of chromosome 22 alleles in human sporadic spinal schwannomas (1991) (20)
- Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. (1991) (20)
- Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures (2009) (20)
- Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration. (1996) (20)
- Adjuvant radiotherapy versus surveillance following surgical resection of atypical meningiomas. (2020) (19)
- Cingulotomy in a case of concomitant obsessive-compulsive disorder and Tourette's syndrome. (1994) (18)
- Review Article : Antiangiogenesis in Neurofibromatosis 1 (2002) (17)
- Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade (2017) (17)
- Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells (2019) (16)
- Sarcomatous proliferation of the vasculature in a subependymoma (2004) (16)
- Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma (2020) (15)
- Glutamate accumulation by human gliomas and meningiomas in tissue culture (1976) (15)
- Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids (2005) (15)
- Brain Tumor Therapy Using Genetically Engineered Replication-Competent Virus (1995) (14)
- Antiangiogenesis in neurofibromatosis 1. (2002) (13)
- Cytotoxicity of human brain tumors by hematoporphyrin derivative. (1986) (13)
- Patel glioblastoma Single-cell RNA-seq highlights intratumoral heterogeneity in primary (2014) (12)
- Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase. (1998) (12)
- Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma. (2016) (12)
- Genetics in neuro-oncology. (1983) (11)
- Hormonal modulation of Schwann cell tumors. I. The effects of estradiol and tamoxifen on methylnitrosourea-induced rat Schwann cell tumors. (1986) (11)
- Characteristics of human optic gliomas in tissue culture. (1977) (11)
- Virus-Mediated Genetic Treatment of Rodent Gliomas (1994) (11)
- Oncolytic herpes simplex virus therapy for peripheral nerve tumors. (2007) (11)
- CT changes of an intracranial granulocytic sarcoma on short-term follow-up. (2003) (11)
- A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma (2019) (10)
- Hormonal Modulation of Schwann Cell Tumors a (1986) (10)
- Molecular neurosurgery for glial and neuronal disorders. (1992) (10)
- In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV (2021) (10)
- Equal parental origin of chromosome 22 losses in human sporadic meningioma: no evidence for genomic imprinting. (1990) (9)
- Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation (2004) (9)
- Evaporation as a cause of positional differences in cell plating and growth in microtiter plates. (1976) (9)
- Facial pain associated with a middle fossa arachnoid cyst. (1981) (8)
- 24‐Year‐Old Woman with An Internal Auditory Canal Mass (2013) (8)
- Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy (2019) (8)
- Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair. (2006) (7)
- Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis. (1987) (7)
- A lymphocyte-dependent antibody assay for detection of antibodies to human glioma cells. (1975) (7)
- Laser-tissue interaction at 1.9 µm (1986) (6)
- Gene therapies for glioblastomas. (1996) (6)
- Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2019) (6)
- Viral Oncolysis of Glioblastoma (2016) (6)
- Cytotoxic antibodies in preoperative glioma patients: A diagnostic assay (1976) (5)
- Bilateral Acoustic Neurofibromatosis (Neurofibromatosis 2): A Disorder Distinct from Von Recklinghausen's Neurofibromatosis (Neurofibromatosis 1) (1991) (5)
- Erratum: Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2 (Human Gene Therapy (January 2006) 17, 1 (20-30)) (2006) (4)
- Benign Meningiomas With Atypical Features: Correlation of Histopathological Features With Clinical Outcomes (2013) (4)
- 142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis. (2016) (4)
- Seizures due to metrizamide myelography in patients with acute cervical spine injury. (1982) (3)
- A new 1.9-µ wavelength laser for neurosurgery (1990) (3)
- Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative (1988) (3)
- Anesthesia for Suboccipital Craniotomy in a Patient with Lymphangioleiomyomatosis: A Case Report (2012) (3)
- Atypical histopathological features and the risk of treatment failure in non-malignant meningiomas: a multi-institutional analysis. (2019) (3)
- Vestibular schwannoma: suboccipital approach. (2014) (3)
- Chapter 45 – Suboccipital Retrosigmoid Surgical Approach for Vestibular Schwannoma (Acoustic Neuroma) (2012) (3)
- Abstract 1122: ATR inhibitors synergize with PARP inhibitors in killing glioblastoma stem cells and treating glioblastoma (2017) (3)
- Clinical Diagnosis of von Recklinghausen's Neurofibromatosis (1986) (3)
- Cancer Therapy : Preclinical A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase / Akt Pathway Inhibitors to Target Glioblastoma Stem Cells (2011) (2)
- Abstract B116: Immunovirotherapy in combination with immune checkpoint inhibitors for treating glioblastoma (2016) (2)
- EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2013) (2)
- Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS. (1994) (2)
- Performance of a Hospital Pathway for Patients With a New Single Brain Mass. (2019) (2)
- Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model Volume 169, Number 1 (2001), pages 64–71 (2001) (2)
- Experimental Therapy for Malignant Brain Tumors Using Genetically Engineered Herpes Simplex Virus Type 1 (1996) (2)
- Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA. (1999) (1)
- Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma (2022) (1)
- 790 Pediatric Acoustic Neuromas: NF2 and Sporadic Tumors (2001) (1)
- 142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis. (2016) (1)
- 798. Intracarotid Delivery of Oncolytic Herpes Simplex Virus-1 G47|[Delta]| to Metastatic Breast Cancer in the Brain (2004) (1)
- 761. Dominant-Negative FGF Receptor Expression by Oncolytic HSV Vector for the Treatment of Malignant Peripheral Nerve Sheath Tumors (2005) (1)
- 624. Immunovirotherapy Combined with Immune Checkpoint Inhibitors for Treating Glioblastoma (2015) (1)
- 1 – Molecular Genetic Analysis of the Phakomatoses (1991) (1)
- RESTRICTION OF γ34.5-DELETED ONCOLYTIC HERPES SIMPLEX VIRUS REPLICATION IN GLIOBLASTOMA STEM-LIKE CELLS. (2018) (1)
- A new 1.9-mu wavelength laser for neurosurgery. (1990) (1)
- Subject Index Vol. 59, 1992 (1992) (1)
- Vestibular schwannoma. Authors' reply (2006) (1)
- Glioblastoma Hypoxia Promotes Oncolytic HSV Replication in vitro and in vivo: 871 (2008) (0)
- LAB-STEM CELLS (2012) (0)
- Replication of herpes simplex specific tissue or cell virus. (1996) (0)
- Prevention andcontrol ofneurofibromatosi s: Memorandumfromajoint WHO/NNFFmeeting* (1992) (0)
- INTERACTIVE REPEATABLE TETFING: A MANY--FACETZD TOOL' (1975) (0)
- 351. Enhanced Therapeutic Efficacy of a Cytokine Expressing Oncolytic Herpes Simplex Virus Against Prostate Cancer (2004) (0)
- Timing of Adjuvant Radiotherapy in Atypical Meningiomas (2020) (0)
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2018) (0)
- TMIC-25. MODIFICATION OF EXTRACELLULAR MATRIX ENHANCES ONCOLYTIC ADENOVIRUS IMMUNOTHERAPY IN GLIOBLASTOMA (2019) (0)
- Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma (2019) (0)
- DNA Transfection Analysis of the Tumors of Neurofibromatosis (1986) (0)
- 107. Tracking Target Cell Fate After Oncolytic Herpes Simplex Virus Infection (2016) (0)
- 160. Systemic Oncolytic Herpes Simplex Virus Therapy of Spontaneously Arising Prostate Cancer in Transgenic TRAMP Mice|[ast]| (2005) (0)
- Destruction of virus-mediated neoplastic cells (1991) (0)
- STEM-22LARGE-SCALE SINGLE-CELL RNA-seq REVEALS A DEVELOPMENTAL CELLULAR HIERARCHY IN HUMAN OLIGODENDROGLIOMA. (2015) (0)
- Lossofdistinct regions ontheshort armofchromosome 17 associated withtumorigenesis ofhumanastrocytomas (1989) (0)
- MNGO-16ESTABLISHMENT OF A PATIENT - DERIVED ORTHOTOPIC MALIGNANT MENINGIOMA MODEL FOR THE DEVELOPMENT OF TARGETED THERAPY (2015) (0)
- A NOVEL NEW TREATMENT FOR PROSTATE CANCER WITH A CONDITIONALLY REPLICATING HERPES SIMPLEX-1 VIRUS, G207 (1999) (0)
- Neurotropic Viral Infections: Viral oncolysis of glioblastoma (2008) (0)
- 1119 : Comparison of Fractionated Stereotactic Radiotherapy With Proton Radiosurgery for Vestibular Schwannoma: A Risk-Stratified Analysis (2006) (0)
- Atypical Histopathological Features and the Risk of Progression/Recurrence in WHO Grade I-II Meningiomas (2018) (0)
- Clonal Analysis of Human Meningiomas and Schwannomas1 (2006) (0)
- 198 Of Mice and Men: Matched Observations of Lymphopenia, Splenic Retraction, and the Bone Marrow as Harbor for Lost T-cells in Mice and Patients With Glioblastoma (2013) (0)
- Immunologic Approaches for Oncolytic Viral Therapy of Prostate Cancer (2005) (0)
- Histopathologic Prognostic Factors of Recurrence Following Surgery and Radiation Therapy for Atypical and Malignant Meningiomas (2016) (0)
- Gene sequences transfer and -exprimierung in cells of the central nervous system with mutant herpes simplex virus containing deletions in virus replication genes (1991) (0)
- Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy (2019) (0)
- Imaging , Diagnosis , Prognosis Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (0)
- Next-Generation Sequencing of Sporadic Schwannomas Reveals Critical Importance of NF2 Alteration (2016) (0)
- Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma (2020) (0)
- Prognosis Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (0)
- Radiosurgery versus Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma (2008) (0)
- 151. Treatment of Experimental Schwannomas with HSV Recombinant and Amplicon Vectors (2006) (0)
- Transfer and expression of gene sequences in cells of the central nervous system using mutants of herpes simplex virus with deletions in genes for viral replication. (1991) (0)
- EXTH-20. HISTONE DEACETYLASE INHIBITOR ENHANCES ONCOLYTIC HERPES SIMPLEX VIRUS THERAPY FOR MALIGNANT MENINGIOMA (2018) (0)
- Abstract 5389: Oncolytic herpes simplex virus expressing interleukin-12 for treating glioma stem cells (2011) (0)
- CSIG-33. BETA 1 INTEGRIN INHIBITION IN HIGH-GRADE MENINGIOMA (2017) (0)
- Genetic Alterations of Nervous System Tumors (1991) (0)
- Long-Term Outcome after Proton-Beam Radiosurgery for Vestibular Schwannoma (2012) (0)
- 1308 Defective herpes simplex virus vectors for the study of l1 gene transfer into the nervous system (1996) (0)
- 840 Enhanced Replication of Oncolytic Herpes Simplex Virus in Glioma Cells that Evade Temozolomide Chemotherapy through DNA Repair. (2005) (0)
- Antitumor Activity Virus Combination Induces Local and Systemic Vector / Replication-Competent Herpes Simplex In Situ Cancer Vaccination : An IL-12 Defective (1998) (0)
- Herpes Virus Therapy of Prostate Cancer (1999) (0)
- Evidence for presence of a virus in glioblastoma multiforme cells. (1973) (0)
- BENIGN INTRASPINAL NERVE SHEATH TUMORS (SNST): THEIR OCCURRENCE SPORADICALLY AND IN CASES OF NEUROFIBROMATOSIS 1 (NF-1) AND 2 (NF-2) (1990) (0)
- ET-17TRANSIENT FASTING ENHANCES REPLICATION AND THERAPEUTIC ACTIVITY OF ONCOLYTIC HSV IN GLIOBLASTOMA THERAPY (2014) (0)
- AI-21HIF-1A TARGETING IN AN ORTHOTOPIC XENOGRAFT MODEL THAT RECAPITULATES THE HYPOXIC MICROENVIRONMENT OF GLIOBLASTOMA. (2014) (0)
- Abstract 2568: Combination treatment of bevacizumab and oncolytic HSV armed with angiostatin show enhanced antitumoral and antiangiogenic effects (2011) (0)
- The transfer to and expression of gene sequences into cells of the central nervous system, using Herpes simplex virus mutants with deletions in the genes for viral replication (1991) (0)
- Abstract 4227: PARP inhibitors sensitize glioblastoma stem cells to oncolytic herpes simplex virus therapy (2015) (0)
- Abstract C176: Combining oncolytic herpes simplex virus and chemotherapy: G47 and temozolomide synergize in killing glioma stem cells (2009) (0)
- Herpes Simplex Virus Vector Factor Activity by Transcriptionally Targeted Oncolytic-Catenin / T-Cell β Effective Treatment of Tumors with Strong (2006) (0)
- Cancer Therapy : Preclinical Enhanced Antitumor Ef fi cacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts (2011) (0)
- Tumor Models (In Vivo/In Vitro) (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert L. Martuza?
Robert L. Martuza is affiliated with the following schools: